Read by QxMD icon Read

Journal of Interventional Cardiology

Christian Roth, Clemens Gangl, Daniel Dalos, Georg Delle-Karth, Thomas Neunteufl, Rudolf Berger
OBJECTIVES AND BACKGROUND: Polymer coatings of drug-eluting stents (DES) may induce allergic reactions and inflammation, resulting in late-acquired stent malapposition (LASM) with the risk of stent thrombosis. This study evaluated, if biodegradable polymer (BP) reduces the incidence of LASM compared to permanent polymer (PP) after treatment with newer generation DES. METHODS AND RESULTS: Fifty patients with 59 lesions were randomized (2:1) to elective treatment with second generation PP-DES (n = 32, 39 stents), either Everolimus-eluting or Zotarolimus-eluting stents, or with BP-DES (Biolimus-eluting stents [BES]; n = 18, 20 stents) and underwent optical coherence tomography directly after implantation and after 1 year...
December 2018: Journal of Interventional Cardiology
Lin Jiang, Zhan Gao, Ying Song, Jingjing Xu, Xiaofang Tang, Huanhuan Wang, Ru Liu, Ping Jiang, Bo Xu, Jinqing Yuan
OBJECTIVES: To investigate the impact of anemia on 2-year outcomes in patients undergoing contemporary percutaneous coronary intervention (PCI). BACKGROUND: Whether anemia is an independent predictor of adverse outcomes after PCI is under debate. METHODS: A total of 10 717 consecutive patients who underwent PCI with available hemoglobin values at Fuwai Hospital were collected. Clinical outcomes were compared between patients with and without anemia both before and after PCI procedure...
December 2018: Journal of Interventional Cardiology
Tomasz Gasior, Norman Mangner, Julia Bijoch, Wojciech Wojakowski
In the recent years, ischemic brain injury related to embolization after transcatheter aortic valve replacement (TAVR) has received increased attention as new embolic protection strategies emerged to protect the brain. Diverse cerebral protection devices have been developed to reduce cerebral embolization during TAVR. These devices work through various mechanisms and are in different stages of clinical translation. This review provides the evidence-based review of peri-procedural stroke prevention during TAVR and summarizes currently available cerebral embolic protection devices...
December 2018: Journal of Interventional Cardiology
Marina Pieri, Tania Sorrentino, Michele Oppizzi, Giulio Melisurgo, Rosalba Lembo, Antonio Colombo, Alberto Zangrillo, Federico Pappalardo
OBJECTIVES: Aim of the study was to assess in-hospital survival rate and the degree of myocardial recovery after MCS treatment (IABP or IMPELLA) at discharge and at 6 months in patients with AMI-CS and planned early percutaneous revascularization. BACKGROUND: All studies on MCS for acute myocardial infarction related cardiogenic shock (AMI-CS) focused on its impact on in-hospital mortality; however, few data about its role on myocardial recovery are available. METHODS: Retrospective study on 64 patients: 36 patients (56%) received IABP and 28 (44%) Impella 2...
December 2018: Journal of Interventional Cardiology
Amir Kaki, Nimrod Blank, M Chadi Alraies, Marvin Kajy, Cindy L Grines, Reema Hasan, Wah Wah Htun, James Glazier, Tamam Mohamad, Mahir Elder, Theodore Schreiber
Femoral and radial artery access continue to be the standard of care for percutaneous coronary interventions. Cardiac catheterization has progressed to encompass a wide range of diagnostic and interventional procedures including coronary, peripheral, endovascular, and structural heart disease interventions. Despite advanced technology to make these procedures safe, bleeding, and vascular complications continue to be a substantial source of morbidity, especially in patients undergoing large-bore access procedures...
December 2018: Journal of Interventional Cardiology
Bruna Gomes, Nicolas A Geis, Florian Leuschner, Benjamin Meder, Mathias Konstandin, Hugo A Katus, Raffi Bekeredjian
BACKGROUND: To date, there are no guidelines recommending a specific prophylactic antibiotic treatment in transcatheter aortic valve replacement (TAVR). The aim of this study is to evaluate clinical data after TAVR with different periprocedural antibiotic regimens. METHODS: In May 2015 the institutional rules for periprocedural antibiotic prophylaxis were changed from 3 days to 1 day. Thus, a total of 450 consecutive TAVR patients between February 2014 and June 2016 were classified into two intention-to-treat groups: patients receiving a 1-day Cefuroxime prophylaxis (N = 225); patients receiving a 3-day Cefuroxime prophylaxis (N = 225)...
December 2018: Journal of Interventional Cardiology
Rico Osteresch, Kathrin Diehl, Matthias Kühl, Eduard Fiehn, Johannes Schmucker, Tina Backhaus, Andreas Fach, Harm Wienbergen, Rainer Hambrecht
AIMS: To evaluate the impact of right ventricular dysfunction (RVD) on outcome after transcatheter mitral valve repair (TMVR) in patients with chronic heart failure (CHF) and severe functional mitral regurgitation (FMR). METHODS AND RESULTS: One hundred thirty patients (median age 72.7 ± 10.7 years; 63.8% male) at high operative risk (LogEuroSCORE 23.8 ± 13.9%) with FMR and CHF (left ventricular ejection fraction 32 ± 7%) were enrolled and separated into two groups according to the RVD...
December 2018: Journal of Interventional Cardiology
Sabry Omar, Garrison L Morgan, Hemang B Panchal, Vinod Thourani, Charanjit S Rihal, Ruchi Patel, Nisharahmed Kherada, Alexander C Egbe, Nirat Beohar
BACKGROUND: Post-myocardial infarction (MI) ventricular septal defects (PIVSD) are an uncommon but life-threatening complication of acute MI. Although surgical closure has been the standard of care, mortality, and recurrence of VSD remain high even after emergent surgery. Transcatheter VSD closure (TCC) devices have become an alternative or adjunct to surgical closure. METHODS: Online database search was performed for studies that included adults with PIVSD who underwent medical treatment (MT) alone, surgical closure (SC) (early or late), and TCC (early, late, or for post-surgical residual VSD)...
December 2018: Journal of Interventional Cardiology
George Bazoukis, Emmanouil S Brilakis, Gary Tse, Konstantinos P Letsas, Panagiotis Kitsoulis, Tong Liu, Adrian Baranchuk, Antonios Sideris, Costas Tsioufis, Stavros Stavrakis
OBJECTIVES: The aim of our systematic review was to investigate the efficacy of coronary sinus (CS) reducer device in patients with refractory angina. BACKGROUND: The CS reducer device provides a therapeutic option for patients with coronary artery disease who are not suitable for revascularization. METHODS: Two independent investigators (GB and GT) systematically searched the Medline and Cochrane library databases for studies describing the efficacy and safety of the CS reducer in patients with refractory angina from January 1, 2000 until May 12, 2018 using the following terms: "coronary sinus (reducer OR reducing) device...
December 2018: Journal of Interventional Cardiology
John Joseph Coughlan, Aiste Zebrauskaite, Samer Arnous, Thomas J Kiernan
AIMS: In 2017, Kiemeneij published a paper on distal trans-radial artery access for coronary angiography in 62 patients. This paper proposed several advantages to this method. Since this paper was published, several other papers have been published describing this technique, with less than 200 cases in total described. We performed a non randomized control study of left distal trans-radial access in patients undergoing coronary angiography in our center. METHODS: We prospectively identified patients presenting for coronary angiography to our center for enrolment in this study...
December 2018: Journal of Interventional Cardiology
Ding Peng, Jing-Hua Liu
OBJECTIVE: This study aimed to explore the predictive factors for left ventricular ejection fraction (LVEF) improvement after revascularization. METHODS: This real-world study examined 993 patients with ischemic HFrEF who had received revascularization (PCI or CABG), had survived at least 90 days and had undergone an echocardiography review. Based on the change in the LVEF, we divided the patients into two groups. RESULT: We obtained 454 patients with ≥10% improvement and 539 with <10% improvement or deterioration...
December 2018: Journal of Interventional Cardiology
Daisuke Hachinohe, Yoshifumi Kashima, Kazuya Hirata, Daitaro Kanno, Ken Kobayashi, Umihiko Kaneko, Takuro Sugie, Yutaka Tadano, Tomohiko Watanabe, Hidemasa Shitan, Takuya Haraguchi, Morio Enomoto, Katsuhiko Sato, Tsutomu Fujita
OBJECTIVES: This study aimed to evaluate the outcomes of patients with in-stent restenosis (ISR) who underwent rotablation (RA) followed by balloon angioplasty (BA), drug-eluting stent (DES) implantation, or drug-coated balloon (DCB) angioplasty. BACKGROUND: Interventional treatment of ISR is occasionally challenging. Despite the availability of various percutaneous treatments, the optimal solution remains unclear. METHODS AND RESULTS: A total of 200 patients with ISR who underwent RA were retrospectively identified from our institutional database...
December 2018: Journal of Interventional Cardiology
Jia Liu, Shaoliang Chen, Jianrui Wei, Fang Zeng, Li Li
OBJECTIVES: We compared the potential benefits of mini-KBI (M-KBI), an optimized kissing balloon inflation (KBI), and classical KBI (C-KBI) in provisional bifurcation stenting. BACKGROUND: The long-term clinical outcomes of C-KBI in a provisional stenting strategy continue to be under debate due to main vessel (MV) stent deformation and overexpansion. METHODS: Twelve stents were deployed in a silicone coronary bifurcation model using a provisional stenting strategy: C-KBI (two non-compliant balloons juxtaposed within the MV stent) was performed in six cases, and M-KBI (the side branch (SB) balloon protruded only into the MV at the upper edge of the SB ostium) was performed in the remaining six cases, all of which were followed by proximal optimization technique POT...
December 2018: Journal of Interventional Cardiology
Ahmed Subahi, Ahmad Munir, Hossam Abubakar, Emmanuel Akintoye, Ahmed S Yassin, Oluwole Adegbala, Mohamed Chadi Alraies, Mahir Elder, Tamam Mohamad, Amir Kaki, Theodore Schreiber
BACKGROUND: The concomitant presence of atrial fibrillation (AF) in the setting of Transcatheter Mitral Valve Repair (TMVR) represents a clinical challenge. Despite the high AF burden in patients presenting for the TMVR procedure, there are no studies that evaluate the impact of AF on in-hospital outcomes of TMVR in a nationally representative United States sample reflecting real practice. Therefore, we sought to study the outcomes of AF patients undergoing TMVR. METHODS AND RESULTS: The study included 1026 patients from the National Inpatient Sample (NIS) registry...
November 19, 2018: Journal of Interventional Cardiology
Jenny E Zablah, Rachel Fry, Michael Ross, Neil Wilson, Gareth Morgan
BACKGROUND: Percutaneous stent implantation in the coronary artery is a potential bailout option after coronary compression during Transcatheter pulmonary valve replacement, but the structural integrity of the coronary stent in this environment is uncertain. METHODS: An invitro model was constructed to represent the interaction between coronary and outflow tract stents. One AndraStent, four CP stents, one Edwards SAPIEN XT valve stent and combination of AndraStent with CP stent were incrementally compressed against a coronary stent...
October 28, 2018: Journal of Interventional Cardiology
Hisato Takagi, Yosuke Hari, Norikazu Kawai, Tomo Ando
OBJECTIVES: We performed a meta-analysis of transcatheter mitral valve implantation (TMVI) for deteriorated bioprosthetic valves (valve-in-valve [VIV]-TMVI) and/or failed annuloplasty rings (valve-in-ring [VIR]-TMVI), comparing observed early (30-day) mortality with predicted operative mortality. BACKGROUND: It remains unclear whether VIV/VIR-TMVI reduces mortality as compared with redo MVS. METHODS: MEDLINE and EMBASE were searched current through 24 July 2018 using Web-based search engines (PubMed and OVID) to identify studies including ≥10 patients undergoing VIV/VIR-TMVI...
October 11, 2018: Journal of Interventional Cardiology
Kamia Thakur, Tamim M Nazif, Omar K Khalique, Jean-Michel Paradis, Kishore J Harjai
This article is a continuation of our previously published annual reviews of transcatheter aortic valve replacement (TAVR). In 2017, TAVR further established a foothold in the management of intermediate risk patients with the publication of SURTAVI trial. Randomized trials also addressed the use of cerebral protection during TAVR and single versus dual antiplatelet therapy after TAVR. Newer generation valve systems continued to be studied for their efficacy and safety. This paper summarizes the major studies published in 2017...
October 2018: Journal of Interventional Cardiology
Yuji Matsuda, Takashi Ashikaga, Taro Sasaoka, Yu Hatano, Tomoyuki Umemoto, Takanobu Yamamoto, Yasuhiro Maejima, Kenzo Hirao
OBJECTIVES: To evaluate the effectiveness of the proximal optimization technique (POT) to prevent longitudinal stent elongation. BACKGROUND: The mechanism of stent elongation, which occurs after post-balloon dilation, is still unclear. METHODS: A total of 103 lesions treated with optical coherence tomography guided coronary intervention between May 2013 and November 2017 were retrospectively analyzed. Lesions were divided according to the circumferential degree of malapposition at the stent edge immediately after deployment into well-apposed group (<180°) and malapposed group (≥180°)...
October 2018: Journal of Interventional Cardiology
Michael Megaly, Marwan Saad, Peter Tajti, M Nicholas Burke, Ivan Chavez, Mario Gössl, Daniel Lips, Michael Mooney, Anil Poulose, Paul Sorajja, Jay Traverse, Yale Wang, Louis P Kohl, Steven M Bradley, Emmanouil S Brilakis
BACKGROUND: We sought to examine the impact of coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) on left ventricular (LV) function. METHODS: We performed a systematic review and meta-analysis of studies published between January 1980 and November 2017 on the impact of successful CTO PCI on LV function. RESULTS: A total of 34 observational studies including 2735 patients were included in the meta-analysis. Over a weighted mean follow-up of 7...
October 2018: Journal of Interventional Cardiology
Katarzyna Mitrega, Witold Streb, Magdalena Szymala, Tomasz Podolecki, Anna Leopold-Jadczyk, Stanislaw Morawski, Zbigniew Kalarus
AIM: Left atrial appendage occlusion (LAAO) is a technique for preventing thromboembolism in patients with atrial fibrillation and a high risk of irreversible bleeding. In some patients, a spontaneous iatrogenic transseptal leak (ITL) remains after LAAO. The aim of this study was to assess the correlation between ITL incidence and the results of cardiac function tests in patients who underwent LAAO. METHODS AND RESULTS: LAOO was performed in 62 consecutive patients using the Amplatzer Amulet...
October 2018: Journal of Interventional Cardiology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"